Esophageal cancer incidence and mortality in China, 2010

Abstract

Background: The National Central Cancer Registry of China (NCCR) is responsible for cancer surveillance. Local cancer registries in each province submit data for annual publication.. The incidence and mortality of esophageal cancer in China in 2010 by age, gender, and area is reported in this article. Methods: There were data from 145 out of 219 qualified cancer registries. Esophageal cancer cases and deaths (ICD 10 code as C15) were stratified by location, gender, age, and cancer site. The 2000 Chinese census and Segi's population were used for age-standardized incidence/mortality rates. The rank in all cancer types and cumulative rate were also calculated. Results: It was estimated that 287 632 new cases were diagnosed and 208 473 patients died from esophageal cancer in 2010 in China. Esophageal cancer incidence ranked fifth of all cancer types with a rate of 21.88/100 000. Age-standardized rates by Chinese population (CASR) and World population (WASR) for incidence and mortality were 16.71/100 000 and 16.97/100 000, respectively. The mortality of esophageal cancer ranked fourth in all cancer types with a rate of 15.85/100 000. The CASR and WASR for mortality were 11.95/100 000 and 12.02/100 000, respectively. For both incidence and mortality, the rates of esophageal cancer were much higher in men than that in women, in rural areas than in urban areas, and peaked at age 80-84. Conclusions: Esophageal cancer is still a major cancer type in rural areas of China. Effective prevention and control should be emphasized, including health education, chemoprevention, and early detection in high-risk groups.

MiR‑148a modulates HLA‑G expression and influences tumor apoptosis in esophageal squamous cell carcinoma

“…EC is the fifth most common type of cancer and esophageal squamous cell carcinoma (ESCC) accounts for 90% of all EC cases (3,4). According to data from the National Central Cancer Registry of China, 477,900 new EC cases and 375,000 cases of mortality occurred in 2015 (5). The majority of EC patients are diagnosed at an advanced stage when the 5-year survival rate is ~20%, though early detected EC can be treated with endoscopic resection, and has a 5-year survival rate of up to 95% (6).…”

18F-fluorodeoxyglucose positron emission computed tomography for monitoring tumor response in esophageal carcinoma treated with concurrent chemoradiotherapy

“…Esophageal squamous cell carcinoma (ESCC) is the 4th most common cause of cancer-associated mortality and the fifth most frequently diagnosed cancer type in China (1). ESCC is a highly aggressive malignancy with a poor prognosis due to the fact that the majority of tumors are asymptomatic until they have reached advanced stages (1).…”

“…ESCC is a highly aggressive malignancy with a poor prognosis due to the fact that the majority of tumors are asymptomatic until they have reached advanced stages (1). At present, concurrent chemoradiotherapy (CRT) has been established as an important approach for patients with locally advanced carcinoma of the esophagus (2).…”

Involved-Field Irradiation in Definitive Chemoradiotherapy for T4 Squamous Cell Carcinoma of the Esophagus

“…Of the two predominant histologic types, adenocarcinoma and squamous cell carcinoma (scc), scc accounts for 95% of all Chinese eca patients, and more than 50% of ecas are at a locally advanced stage when diagnosed 1 . The lack of a serosal layer in the esophagus and the location of this conduit in a very narrow mediastinal space allows for tumour invasion into the local structures, which represents disease stage T4 2 .…”